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Edited by Stuart FergusonAbstract The alternative NADH:ubiquinone oxidoreductase
(NDH-2) from Escherichia coli is a membrane protein playing
a prominent role in respiration by linking the reduction of NADH
to the quinone pool. Remote sequence similarity reveals an evolu-
tionary relation between alternative NADH:quinone oxidoreduc-
tases and the SCOP-family ‘‘FAD/NAD-linked reductases’’. We
have created a structural model for NDH-2 from E. coli through
comparative modelling onto a template from this family. Com-
bined analysis of our model and sequence conservation allowed
us to include the cofactor FAD and the substrate NADH in
atomic detail. Furthermore, we propose the most plausible orien-
tation of NDH-2 relative to the membrane and specify a region of
the protein potentially involved in ubiquinone binding.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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NADH is the central source of electrons in mitochondrial
and bacterial respiration. Two major classes of NADH:qui-
none oxidoreductases link the oxidation of NADH to the
reduction of ubiquinone or menaquinone in the mitochondrial
or inner bacterial membrane. Respiratory complex I in mito-
chondria and related complexes in bacterial membranes
(NDH-1) couple the oxidation of NADH with proton transfer
across the membrane, and hence generate a proton motive
force that is utilised for the synthesis of ATP. NDH-1 is a multi-
subunit protein complex bearing one ﬂavin mononucleotide
(FMN) and a series of Fe–S clusters as cofactors. In contrast,
alternative NADH:quinone oxidoreductases (NDH-2) are not
capable of translocating protons and only a single (45 kDa)
protein has been associated with this reaction. NDH-2 cataly-
ses electron transfer from NADH via FAD to ubiquinone and
displays remote sequence similarity to proteins classiﬁed as
‘‘FAD/NAD-linked reductases’’ 1 in the Structural Classiﬁca-Abbreviations: NDH-1, respiratory complex I; NDH-2, alternative
NADH:ubiquinone oxidoreductase; TM, transmembrane; PDB, pro-
tein data bank; SCOP, structural classiﬁcation of proteins data base;
rmsd, root mean square deviation
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E-mail address: d.gerloﬀ@ed.ac.uk (D.L. Gerloﬀ).
1 FAD/NAD-linked reductases consist of the SCOP-domains c.3.1.5
(FAD/NAD-linked reductases, N-terminal and central domains) and
d.87.1.1 (FAD/NAD-linked reductases, C-terminal domain).
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doi:10.1016/j.febslet.2004.10.093tion of Proteins (SCOP) database (http://scop.mrc-lmb.cam.
ac.uk/scop/). SCOP is curated by experts and provides a de-
tailed and comprehensive classiﬁcation of known protein
structures based on their resemblance and evolutionary consid-
erations [1]. All members of the SCOP-family ‘‘FAD/NAD-
linked reductases’’ have the electron donator NAD(P)H and
the cofactor FAD in common, while the ﬁnal electron acceptor
varies. The similarities in sequence and function suggest
homology modelling as a suitable approach for elucidating
the structural aspects of NDH-2 activity. Structural conserva-
tion between related proteins is particularly high within active
sites, so information regarding enzymatic function can often be
extracted from homology models even if sequence identity be-
tween template and target is low overall (<25%).
NDH-2 type enzymes have been found in mitochondria
from primarily plant and fungal species, and in many bacteria.
So far no tertiary structural information for any of these en-
zymes is available. Various species accomplishing respiration
with NADH as electron source use either NDH-1, NDH-2
or both (see [2] for a review). E. coli expresses predominantly
the respiratory complex I homologue NDH-1 under anoxy-
genic conditions, whereas under oxygenic conditions NDH-2
is signiﬁcantly more abundant [3]. While NDH-2 from E. coli
is one of the best studied alternative NADH:ubiquinone
oxidoreductases little detail is known of the substrate and
cofactor binding sites and the interaction between protein
and membrane is a matter of dispute.2. Methods
2.1. Fold recognition and sequence alignments
The amino acid sequence of E. coli NDH-2 (SWISS-PROT entry:
DHNA_ECOLI) was submitted to the 3D-PSSM [4] (http://
www.sbg.bio.ic.uk/servers/3dpssm/) and SAMT02 [5] (http://
www.cse.ucsc.edu/research/compbio/HMM-apps/T02-query.html)
www-servers for fold recognition, secondary structure prediction and
preliminary sequence alignments. Further homologous sequences to
DHNA_ECOLI and potential templates were retrieved using BLAST
and PSI-BLAST [6] against the non-redundant and SWISS-PROT dat-
abases via the NPS@ www-server (http://npsa-pbil.ibcp.fr) [7]. Multi-
ple alignments were generated using T-Coﬀee [8] and subsequently
subjected to minor manual editing. A sequence alignment of ‘‘FAD/
NAD-linked reductases’’ based on structural superposition of avail-
able 3D structures was produced using pairwise alignments by the
CE www-server (http://cl.sdsc.edu/ce.html) [9]. Sequence alignments
are provided as Supplemental Materials.
2.2. Homology modelling and data analysis
After careful examination of potential templates the structure of
NADH-peroxidase from Enterococcus faecalis (PDB entry: 2NPX)
[10] was chosen for modelling. A pairwise alignment betweenation of European Biochemical Societies.
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taking into consideration multiple sequence alignments, structural
alignments and the continuity of secondary structure elements. Series
of 20 models for alternative plausible alignments were built using
MODELLER 6v2 [11] with added restraints based on predicted sec-
ondary structure (elongating a-helices Pro143–Ser161, Ala179–
Lys201 and Ala330–Met348 by 7, 10 and 4 residues, respectively).
The highest ranking ﬁve models in each series were submitted to the
WHATCHECK www-server (http://www.cmbi.kun.nl/WIWIWI/gv/
servers/) [12] and inspected manually. Non-identical side chains be-
tween template and target were optimised using SCWRL [13], except
if directly involved in binding FAD or NADH. Loop modelling and
energy minimization (Tripos forceﬁeld, 10 steps steepest descent fol-
lowed by 100 steps conjugate gradient) was carried out in SYBYL
6.8 (Tripos Associates, St. Louis). For the prediction of transmem-
brane (TM) helices the NDH-2 sequence was submitted to the follow-
ing servers: TMHMM [14], PHDTM [15], HMMTOP [16], TM-Pred
[17], DAS [18], PRED-TMR [19], TM-Finder [20], TMAP [21],
ALOM2 [22] and SOSUI [23]. Electrostatic surface calculations were
performed using GRASP [24].3. Results and discussion
3.1. NDH-2 belongs to the SCOP-family ‘‘FAD/NAD-linked
reductases’’
Fold recognition reveals unambiguously that NDH-2 is a
member of the SCOP-family ‘‘FAD/NAD-linked reductases’’.
All relevant hits retrieved from searching 3D-PSSM and
SAMT02 with DHNA_ECOLI belong to this family, with E-
values 2 as low as 0.00045 for 3D-PSSM (>95% certainty
according to the web-page), and 5 · 1043 for SAMT02. The
SCOP-family ‘‘FAD/NAD-linked reductases’’ includes 11
functional subfamilies to date. All proteins within the family
facilitate electron transfer reactions from NAD(P)H via the
non-covalently bound cofactor FAD to electron acceptors that
vary for each subfamily (e.g. H2O2, ferredoxin, glutathione),
which suggests that NDH-2 is part of a new subfamily. In con-
trast to the membrane-bound NDH-2, all structurally charac-
terised FAD/NAD-linked reductases are soluble enzymes,
most of them forming homodimers. Each monomer consists
of three domains. The most characteristic feature of the family
is a structural motif consisting of 5 parallel b-strands topped by
3 anti-parallel b-strands which occurs in both the FAD and
NADH-binding domains. The C-terminal dimerisation domain
is the most divergent part amongst the functional subfamilies.
Manual inspection of possible templates from the ‘‘FAD/
NAD-linked reductases’’ family (see Section 2) suggested the
NADH-peroxidase from Enterococcus faecalis (SWISS-PROT
entry: NAPE_ENTFA) as the most suitable template for mod-
elling NDH-2. This is supported by a PSI-BLAST [6] search
with DHNA_ECOLI as query sequence against SWISS-PROT
hitting NAPE_ENTFA in iteration 2 with a score of 151 (E-
value 4 · 1036). Eight structures for NAPE_ENTFA have
been deposited in the PDB to date. Out of these we chose
PDB-entry 2NPX as the only wild-type structure including a
bound NADH substrate [10].
The most crucial step in homology modelling at low (<25%)
sequence identity is the alignment between target and template.
Information extracted from multiple alignments of both the
template and target subfamilies as well as structural alignments
was used to place insertions and deletions. Secondary structure
elements were kept uninterrupted and exposed sites were se-2 E-value = probability of a random hitlected for insertions into the template structure. Ignoring gaps
in the threading alignment DHNA_ECOLI and NAPE_ENT-
FA share 21% sequence identity; a further 25% of the aligned
positions are conservative substitutions.3.2. A control model conﬁrms the suitability of the approach for
modelling NDH-2
The structure of NAPE_ENTFA (PDB-entry: 2NPX) was
modelled based on the structure of lipoamide dehydrogenase
from Pseudomonas putida (PDB-entry: 1LVL) using the same
approach as for modelling NDH-2. The sequence identity be-
tween 2NPX and 1LVL is 23%, a further 21% are conservative
changes. This control experiment allows us to evaluate the
modelling procedure and hence, to estimate the reliability of
the NDH-2 model at diﬀerent levels of detail. The rmsd be-
tween the control model and the corresponding experimentally
determined structure 2NPX was 2.84 A˚ over Ca atoms in the N-
terminal domain (residues 1–321) and 3.18 A˚ over the C-termi-
nal domain (residues 322–444). Excluding four loop insertions
with respect to the template (residues 134–138, 145–148, 284–
295 and 425–431) improves the rmsd to 2.38 A˚ (N-terminal do-
main) and to 2.29 A˚ (C-terminal domain), respectively. For 17
out of the 18 residues within contact distance to FAD (<3.5 A˚)
an excellent 0.81 A˚ rmsd over all atoms (including side chains)
was attained. Putative hydrogen bonds were determined using
the LPC www-server (http://bip.weizmann.ac.il/oca-bin/lpccsu)
with a distance cut-oﬀ of 3.3 A˚ [25]. Of the 16 putative hydro-
gen bonds between protein and FAD that are present in the
2NPX structure, 14 were also detected in the control model.
The electrostatic surfaces of the experimentally determined
structure and the control model revealed no major diﬀerences
but were visibly diﬀerent from that of the template, 1LVL (data
not shown). These results demonstrate that our approach is suf-
ﬁciently accurate to yield a realistic impression of the NDH-2
structure overall, a model of the FAD and NADH binding sites
in atomic detail, and electrostatic surfaces at a resolution allow-
ing qualitative interpretation.3.3. The model of NDH-2 reveals details of the FAD, NADH
and putative ubiquinone and Cu(I) binding sites
Our ﬁnal model for NDH-2 comprises 385 amino acid resi-
dues, the cofactor FAD and the substrate NADH. Both the
FAD and the NADH-binding domains show the characteristic
structural motif (see Section 3.1) and the redox active parts of
the cofactors (i.e. the nicotinamide ring of NADH and the iso-
alloxazine ring of FADH) are orientated in parallel, in close
proximity of each other (<3 A˚), to facilitate electron transfer
(see Fig. 1). Most residues involved in cofactor binding belong
to established ‘‘sequence ﬁngerprints’’ [26,27] and are amongst
the most highly conserved residues within the sequence align-
ments. Since our evaluation suggests that the model of
NDH-2 is most accurate in these areas we are conﬁdent that
the 10 hydrogen bonds found involved in FAD binding, and
the 8 hydrogen bonds to NADH, are a reasonable approxima-
tion of the hydrogen bonding pattern in the actual sites (see
Fig. 2 for details).
The 48 C-terminal residues of NDH-2 could not be modelled
in detail due to ambiguities in the alignment. In all so far
known FAD/NAD-linked reductases the C-terminal domain
is responsible for dimerisation. Since NDH-2 has not been
shown to form a functional dimer, it is perhaps not surprising
Fig. 1. (A) Ribbon representation of modelled alternative NADH:ubiquinone dehydrogenase from E. coli (NDH-2). The ribbon is colour-coded
from N-terminus (blue) to C-terminus (red). FAD and NADH are displayed as ball and stick models coloured in yellow and red, respectively. The
residue identiﬁed as potentially involved in quinone binding, His51, forms part of the light blue helix behind the FAD molecule (not shown). The
diagram was created using MOLSCRIPT [43] and RASTER3D [44]. (B) TOPS-Topology cartoon [45] of the model. Circles and triangles represent a-
helices and b-strands, respectively. The FAD-domain (Thr1–Asn129, Gly274–Gly350), NADH-domain (Thr130–Ala273) and the C-terminal domain
(Lys351–Met385) are coloured in red, yellow and blue, respectively.
Fig. 2. Detailed views of the FAD binding site (A) and the NADH
binding site (B). Displayed are all protein residues within 3.3 A˚ of
FAD or NADH that are likely to be involved in hydrogen bonding to
these cofactors. Atoms are coloured according to CPK (carbon-white;
oxygen-red; nitrogen-blue; phosphorous-orange), carbon atoms in
FAD and NADH are depicted in green for better distinction. The side
chain of Arg40 was omitted for clarity. Predicted hydrogen bonds
between protein and FAD or NADH are indicated by dotted lines. The
ﬁgure was produced using SYBYL 6.8 (Tripos Associates, St. Louis).
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from the template. A possible role for these residues, derived
from secondary structure prediction and sequence analysis is
discussed in Section 3.4.
It is assumed that all FAD/NAD-linked reductases have
evolved from a common ancestor, but acquired their ability to
react with their respective electron acceptors independently
[28]. Indeed, the variety of electron acceptors used is reﬂected
in the only marginal overall sequence conservation throughout
the family at the relevant site. However, subfamily speciﬁc se-
quence conservation is found instead (Supplemental Material).
For example, Cys42 as the oxygen transferring residue in the ac-
tive site of 2NPX is entirely conserved within the subfamily of
NADH-(per)oxidases. In contrast to theFADandNADHbind-
ing sites details of the ubiquinone binding site, such aswhich res-
idues are involved in hydrogen bonding, cannot be derived from
the structural model directly. Instead, deriving information
about the NDH-2 ubiquinone binding site must rely on com-
bined analysis of evolutionary information (such as sequence
conservation within the NDH-2 subfamily), physical restraints
(such as distance dependence of the probability for successful
electron transfer events), and the structural information ob-
tained from homology modelling. To achieve eﬃcient electron
transfer the electron acceptor, (ubiquinone in the case of
NDH-2 and H2O2 for 2NPX) has to be in close proximity of
the cofactor FAD. For example, the acceptor site in 2NPX is
in close contact to the isoalloxazin ring of the FAD molecule
and the residues most crucial for catalysis are located between
strand 2 and strand 3 of the N-terminal 5-stranded b-sheet. This
provides an ideal arrangement for eﬃcient electron transfer
fromNADHviaFAD toH2O2. Similarily, we expect the ubiqui-
none binding site in NDH-2 close to the FAD and the isoallox-
azin ring of FAD ‘‘sandwiched’’ between the nicotinamide of
NADH and ubiquinone. Ubiquinone is a lipid-like, hydropho-
bic compound present primarily in the membrane, therefore its
binding site onNDH-2would also be expected close to themem-
brane. Together this points particularly to the region between
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tion in the NDH-2 subfamily reveals His51 (His or Tyr in the
bacterialNDH-2 in the alignment) as a potential hydrogen bond
donator for ubiquinone at <5 A˚ distance from the FAD-isoal-
loxazine in our model. One could argue that this suggestion is
supported, to an extent, byweak similarity in the sequence align-
ment to a consensus sequence pattern L–X(3)–H–X(3)–(S/T) at
known quinone binding sites described by Fisher et al. [29].
However, these local similarities are clearly too weak to be sig-
niﬁcant and the more recently solved structures of membrane
proteins with quinone binding sites have discouraged the idea
of such a simple sequence motif for quinone binding. Instead
they encourage the idea that subfamily conserved residues may
be involved in hydrogen bonding and proton shuttling [30]. It
is worthwhile mentioning that an ubiquinone site in close con-
tact to FAD, as is proposed here for NDH-2, is reminiscent of
the unspeciﬁc quinone binding site in the solubleNAD(P)H:qui-
none oxidoreductase which resembles the ﬂavodoxin fold [31].
A conserved Trypthophan residue (Trp271 in E. coli NDH-
2) has previously been suggested to be engaged in a p-stacking
interaction with the quinone ring [32]. Our model shows that
Trp271 is part of a sequence stretch interacting with the aden-
osine moiety of NADH. With its aromatic side chain within 6
A˚ distance from the adenine ring, as compared to >15 A˚ to the
redox active nicotinamide of NADH and isoalloxazin of FAD,
we conclude that this residue is not involved in quinone bind-
ing, but part of the hydrophobic pocket binding the NADH-
adenine.
Recently, the reduction of Cu(II) was reported as an addi-
tional function of NDH-2 [33], and a putative Cu(I) binding site
formed mainly by Cys315 and Cys318, with Cys137, His334 or
Cys339 as potential additional ligands, was postulated [34]. To
test this hypothesis, we built an additional NDH-2 model using
distance restraints to force the sulphur atoms of Cys315 and
Cys318 into a distance suitable for coordination of a Cu(I)-
ion without ﬁnding major distortions of the overall fold.
Assuming that Cys315 and Cys318 are indeed part of a Cu(I)
binding site, Cys137 is unlikely to also be involved since it is
>25 A˚ away. His334 and Cys339 are part of a helix (Ala330–
Asn349) which extends along the putative Cu(I) binding site,
but neither is pointing towards it. While the possibility of an in-
duced conformational change upon metal binding cannot be
ruled out entirely and could potentially modify the availability
of Cys137 for coordination, the orientation of this helix is
unambiguously determined by the positions of the highly con-
served Ala330 and Ala333 which are facing the ﬂavin part of
FAD and are part of its binding site. Based on our model
Met336 and Lys354 (assuming an uncharged lysine side chain)
would make more plausible additional ligands of Cu(I). How-
ever, there is no obvious conserved ‘‘ﬁngerprint’’ in the se-
quence alignment that would link Cys315, Cys318, Met336
and/or Lys354. In the absence of further experimental evidence,
the lack of a noticeable conservation pattern at any of the posi-
tions including candidates for its coordination must be taken to
suggest that Cu(I) binding is a feature limited to, at best, the
closest homologues of E. coli NDH-2.3.4. Membrane interaction of NDH-2 seems to be mediated by
amphipathic helices and electrostatic interactions
Membrane binding is a unique feature of the NDH-subfam-
ily within the ‘‘FAD/NAD-linked reductases’’ SCOP-family.In general, protein binding to membranes is mediated by
hydrophobic interactions (e.g. through transmembrane helices)
and electrostatic interactions (mainly between positively
charged protein residues and negatively charged phosphatidyl
groups on the membrane surface). Recently, improvements in
TM- and membrane topology prediction have been reported
when consensus predictions were based on several methods
[35]. Accordingly we submitted the NDH-2 sequence to 10 dif-
ferent TM-prediction servers and analysed the results. Five
methods (TMHMM [14], PRED-TMR [19], TMAP [21],
ALOM2 [22], SOSUI [23]) predicted no TM-helices at all.
DAS [18] predicted only short (<8 residues) TM-regions which
are unlikely to form membrane spanning helices. PHDTM
[15], TMPred [17], TM-Finder [20], and HMMTOP [16] pre-
dicted one, or several, TM-helices at the C-terminus, but these
methods produce a higher proportion of false positive results
(typically from 11% HMMTOP to 55% TMPred by contrast
to <2% TMHMM [36]). Automated secondary structure pre-
diction for this region predicts one long, or two shorter, a-heli-
ces between Ile393 and Ile422. A more thorough analysis of
sequence conservation and topology as described in [37] sug-
gests the presence of two helices (Arg390–Ala406, Gly409–
Arg424), both displaying amphipathic properties as is typical
for helices on the protein surface (Fig. 3). The preference for
positively charged residues on the hydrophilic side of these pre-
dicted helices, in combination with the relatively high abun-
dance of tryptophan and tyrosine residues which are known
to be important for membrane binding [38], makes them likely
candidate sites of interaction with the phosphatidyl groups of
the membrane. Our analysis cannot completely rule out the
possibility of a single C-terminal TM-helix but this would
place His408–Tyr410 in E. coliNDH-2 in its centre, while these
residues are matched by a stretch of three charged/polar resi-
dues in several other members of the NDH-2 subfamily (for
details see Supplemental Material). Contrary to proteins with
multiple TM-helices NDH-2 could not compensate for such
charges through inter-TM-helix salt bridges and a TM-helix
bearing this feature would presumably be energetically
disfavoured.
To identify possible electrostatic protein–membrane interac-
tions we compared the electrostatic surfaces of NDH-2 (mem-
brane binding) and 2NPX (soluble). 2NPX has a net charge of
19 while NDH-2 has a positive net charge of +6. Positively
charged protein residues are generally favourable for interact-
ing with membrane surfaces; the inner membrane of E. coli, for
example, contains 20–25% negatively charged lipids [39]. Com-
paring the NADH-peroxidase structure and the model for
NDH-2 reveals a four residue patch of solely positively
charged amino acids in NDH-2 (Arg29–Lys32). Three of these
residues are absent in the NADH-peroxidase. Equivalent posi-
tive patches are present in the closest homologues to E. coli
NDH-2. Considering the position of this insertion in combina-
tion with the location of the two predicted amphipathic C-ter-
minal helices suggests that NDH-2, in the orientation in which
it is displayed in Fig. 1, must be topping the membrane. In this
arrangement the adenosine part of NADH is pointing towards
the cytosol and the isoalloxazine ring of FAD is close to the
membrane. The potential ubiquinone binding site (see Section
3.3) is located between the FAD ring plane and the membrane.
This orientation would appear optimal for electron transfer
from NADH to ubiquinone and subsequent exchange with
the membrane quinone pool.
Fig. 3. Helix-wheel representations of the two predicted C-terminal helices (Panel A: Arg390–Ala406; Panel B: Gly409–Arg424) for the NDH-2
subfamily alignment (E-value cutoﬀ 1030, with respect to E. coliNDH-2). Two distinguishable groups are treated separately; sequences belonging to
the DHNA_ECOLI group are displayed on the outside of the helix wheel, sequences belonging to the YLID_BACSU group on the inside. The
groups consist of 14 and 13 sequences, respectively. Diﬀerent font sizes denote the number of occurrences of the respective residue in the alignment
(1–2; 3–5; 6–10; >10). The colouring scheme matches physical properties of the residues at each position; blue boxes correspond to predominantly
positively charged residues; light blue boxes to predominantly hydrophilic residues, yellow boxes to predominantly hydrophobic residues and violet
boxes to Trp, Tyr and His, i.e. polar aromatic residues which are potentially important for membrane binding.
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from E. coli with the membrane have previously been derived
from sequence studies [34,40,41]. Finel [40] suggested that
binding between membrane and protein is accomplished by
amphipathic interactions with residues Leu242 to Thr247. In
our model most of these residues are within 5 A˚ of the adeno-
sine moiety of NADH. Since in the reaction cycle NAD+ is re-
placed by NADH from the cytosol they are much more likely
to be in contact with the cytosol than the membrane. Contrary
to Finel, Rapisarda et al. [34] postulated two C-terminal trans-
membrane helices acting as membrane anchors for NDH-2
based on TM-predictions by PHDTM and HMMTOP. How-
ever, the lengths of the suggested TM-helices, 11 and 13 resi-
dues respectively, seem too short for spanning the entire
membrane. Therefore, we propose our model here as a more
plausible approximation of the interaction between NDH-2
and membrane.
3.5. NDH-2 from E. coli in relation to alternative
NADH:ubiquinone oxidoreductases from fungi, plants and
bacteria
Alternative NADH:quinone oxidoreductases are found in
bacteria and in mitochondria of fungi and plants. While most
bacteria seem to have only one, two NDH-2 enzymes co-exist
in some eukaryotic species facing either the mitochondrial ma-
trix, or the cytoplasm. From sequence alignments these NDH-
2 enzymes appear to be paralogs resulting from gene duplica-
tion events after speciﬁcation (see [2] for discussion). Further
in contrast to bacterial NDH-2, most eukaryotic NDH-2 have
an N-terminal extension for which the structural model of
E. coli NDH-2 obviously cannot account. Nonetheless features
derived from the modelled core structure are likely to be com-
mon in all NDH-2. Speciﬁcally, most of the residues involved
in FAD and NADH binding are within conserved sequence
stretches, therefore we expect that the binding sites of E. coliNDH-2 will be useful models for the FAD and NADH binding
sites in general. Of the residues forming side-chain hydrogen
bonds with FAD or NADH (see Fig. 2) Thr180, Glu214
(Gln or Asp in some species) and Asp314 are conserved
amongst almost all species. Asp39 which is conserved in most
bacterial NDH-2 is matched by a Ser residue in most eukary-
otic NDH-2, while Asn41 and His361 show less overall conser-
vation. Within the proposed ubiquinone binding site His51
(Tyr in some species) and Glu52 (or Gln in some species) are
present in bacterial NDH-2. In eukaryotic NDH-2 the corre-
sponding residues are Pro and Ser, suggesting that the Ser res-
idue may form a hydrogen bond to ubiquinone. By contrast,
potentially Ca2+-binding insertions have been found only in
the potato Solanum tuberosum and the fungus Neurospora
crassa NDH-2 sequences, and proposed to be involved in
membrane association [2,42]. The corresponding insertion site
in the E. coli NDH-2 model could allow a hypothetical Ca2+-
binding domain consisting of two EF-hands to interact with
the membrane. While the same would not hold true for many
other positions in the model, the absence of deﬁnitive template
positions for the linker residues in between the domains means
that alternative locations, farther away from the membrane,
are equally plausible from a modellers perspective. Finally,
the proposal of a NDH-2 membrane interaction via two C-ter-
minal amphiphilic helices is based on the conservation of phys-
ical properties in the alignment of bacterial sequences but
inspection of this region in eukaryotic sequences suggests that
it should apply generally to all NDH-2.4. Availability
Atomic coordinates for E. coli NDH-2 are publicly available
via the PDB as a theoretical model (PDB: 1OZK).
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